ClinicalTrials.gg
Drug

Palonosetron clinical trials

Also written Aloxi and RS 25259-197.

studies test it
71
open now
1
in phase 3
17
first study started
2005

How each study uses Palonosetron is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Palonosetron studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Jul 2003 · ALOXI · NDA 021372 (FDA, Drugs@FDA)
European Union
22 Mar 2005 · Aloxi · EMEA/H/C/000563 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Palonosetron
42
palonosetron hydrochloride
10

Brand

Aloxi
23

Development codes

RS 25259-197
5

In one entry with another drug

Given together, or one or the other

palonosetron with dexamethasone
2

Studies by the year they started

70 studies that test it; most in 2006 (11)

Studies that test Palonosetron, by start year
YearStudies
20051
200611
20072
20083
20098
20103
20117
20123
20132
20141
20156
20165
20174
20184
20192
20203
20223
20231
20251

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
26
Phase 3
17
Phase 4
16
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 55

Helsinn Healthcare SA (7) · M.D. Anderson Cancer Center (4) · Eisai Inc. (3) · University of Malaya (2) · OHSU Knight Cancer Institute (2) · Ajou University School of Medicine (2) · Duke University (2) · Yonsei University (2)

Often tested with

Tested in the same studies.

Dexamethasone (14) · Ondansetron (10) · Aprepitant (7) · Granisetron (5) · Netupitant (3) · Metoclopramide (2) · Propofol (2) · Promethazine (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Palonosetron, phase 3 first.

Studies

Open first, then newest update. How each study uses Palonosetron is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 71

See all 71 studies that test Palonosetron →

Given beside what is tested · 19 — Palonosetron is usual care or a partner of the new treatment
As the comparator · 12 — what is tested is compared with Palonosetron

Codes

What other systems call Palonosetron · ClinicalTrials.gg INT006814

  • MeSH (NLM) D000077924PalonosetronConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 5D06587D6RPALONOSETRONConfirmed FDA, NLM, Wikidata
  • RxNorm 70561Confirmed FDA, Wikidata
  • Wikidata Q419841(3aS)-palonosetronConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61874PalonosetronOne source FDA
  • DrugBank DB00377One source Wikidata

Also registered as palonosetron hydrochloride (UNII 23310D4I19 · RxNorm 397405) and palonosetron, (3r)- (UNII 2UCB21ER4V).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.